Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Flowers

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
ACS Sensors|September 21, 2021
Microfluidic Platform to Transduce Cell Viability to Distinct Flow Pathways for High-Accuracy SensingFatima Ezahra Chrit, Abhishek Raj, Katherine M Young, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2012
Effectiveness of first-line management strategies for stage I follicular lymphoma: analysis of the National LymphoCare StudyJonathan W Friedberg, Michelle Byrtek, Brian K Link, et al.
Leukemia & Lymphoma|May 7, 2010
Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous cathetersHa Tran, Martha Arellano, Abbas Chamsuddin, et al.
APL Bioengineering|July 9, 2020
Stiffness based enrichment of leukemia cells using microfluidicsMuhymin Islam, Abhishek Raj, Brynn McFarland, et al.
Transfusion|March 27, 2007
Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cellsMichelle L Hicks, Sagar Lonial, Amelia Langston, et al.
Current Problems in Cancer|June 15, 2010
ACR Appropriateness Criteria: follow-up of Hodgkin's lymphomaAndrea Ng, Louis S Constine, Ranjan Advani, et al.
Journal of the American College of Radiology : JACR|May 3, 2011
ACR Appropriateness Criteria® on Hodgkin's lymphoma-unfavorable clinical stage I and IIPrajnan Das, Andrea Ng, Louis S Constine, et al.
Cancer Cell|September 22, 2023
A single-cell atlas of CD19 chimeric antigen receptor T cellsXubin Li, Jared Henderson, Max J Gordon, et al.
Blood|April 2, 2020
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPIAmy S Ruppert, Jesse G Dixon, Gilles Salles, et al.
Journal for Immunotherapy of Cancer|October 9, 2025
Germline determinants of toxicity and efficacy in patients with large B-cell lymphoma treated with CAR T-cell therapyPaolo Strati, Amanda Brandt, Anath C Lionel, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
ACS Sensors|September 21, 2021
Microfluidic Platform to Transduce Cell Viability to Distinct Flow Pathways for High-Accuracy SensingFatima Ezahra Chrit, Abhishek Raj, Katherine M Young, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2012
Effectiveness of first-line management strategies for stage I follicular lymphoma: analysis of the National LymphoCare StudyJonathan W Friedberg, Michelle Byrtek, Brian K Link, et al.
Leukemia & Lymphoma|May 7, 2010
Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous cathetersHa Tran, Martha Arellano, Abbas Chamsuddin, et al.
APL Bioengineering|July 9, 2020
Stiffness based enrichment of leukemia cells using microfluidicsMuhymin Islam, Abhishek Raj, Brynn McFarland, et al.
Transfusion|March 27, 2007
Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cellsMichelle L Hicks, Sagar Lonial, Amelia Langston, et al.
Current Problems in Cancer|June 15, 2010
ACR Appropriateness Criteria: follow-up of Hodgkin's lymphomaAndrea Ng, Louis S Constine, Ranjan Advani, et al.
Journal of the American College of Radiology : JACR|May 3, 2011
ACR Appropriateness Criteria® on Hodgkin's lymphoma-unfavorable clinical stage I and IIPrajnan Das, Andrea Ng, Louis S Constine, et al.
Cancer Cell|September 22, 2023
A single-cell atlas of CD19 chimeric antigen receptor T cellsXubin Li, Jared Henderson, Max J Gordon, et al.
Blood|April 2, 2020
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPIAmy S Ruppert, Jesse G Dixon, Gilles Salles, et al.
Journal for Immunotherapy of Cancer|October 9, 2025
Germline determinants of toxicity and efficacy in patients with large B-cell lymphoma treated with CAR T-cell therapyPaolo Strati, Amanda Brandt, Anath C Lionel, et al.
Pageof 7